Detailed Mechanism of Action
Human Growth Hormone (Somatropin) is a recombinant 191-amino acid, single-chain polypeptide that is molecularly identical to the growth hormone produced naturally by somatotroph cells in the anterior pituitary gland. This 36IU vial contains pharmaceutical-grade somatropin manufactured using recombinant DNA (rDNA) technology, ensuring exact sequence fidelity to the endogenous human hormone. HGH exerts its biological effects through both direct and indirect pathways, creating a broad spectrum of anabolic, metabolic, and regenerative actions.
Direct effects of somatropin include stimulation of protein synthesis and tissue repair, promotion of lipolysis (particularly visceral fat breakdown), enhancement of nitrogen retention leading to increased lean body mass, and improvement of calcium absorption and bone mineralization. These direct effects are mediated through GH receptor binding on target tissues including muscle, bone, liver, and adipose tissue. The compound directly shifts the body's metabolic balance toward fat utilization and protein conservation.
Indirect effects are mediated primarily through IGF-1 (Insulin-like Growth Factor 1), which the liver produces in response to circulating growth hormone. IGF-1 is a potent anabolic peptide hormone that drives many of HGH's most recognized effects: muscle growth, cellular repair and regeneration, bone growth (in youth), and tissue remodeling. The GH-IGF-1 axis represents one of the body's most powerful growth and repair signaling cascades. In adults, natural GH production declines approximately 14% per decade after age 30, contributing to age-related changes in body composition, recovery capacity, skin quality, and energy levels.
Clinical Evidence
Human Growth Hormone is one of the most extensively studied peptide hormones in medicine, with decades of clinical trial data across multiple approved indications. For body composition, controlled studies consistently demonstrate preferential reduction in visceral and trunk fat, increased lean body mass, and improved bone mineral density with prolonged therapy. Skin quality improvements — including increased collagen content, improved skin thickness, and enhanced elasticity — have been documented in anti-aging research contexts.
In the body composition context most relevant to this product, studies have shown that exogenous HGH at physiological replacement doses (1-4 IU/day) produces measurable reductions in visceral adipose tissue, increases in lean muscle mass, and improvements in recovery capacity. However, it is important to note that strength gains from HGH alone tend to be modest without accompanying resistance exercise — the compound enhances the body's capacity for muscle protein synthesis but does not independently produce significant strength increases.
The evidence base also establishes clear dose-dependent relationships: higher doses produce more pronounced body composition changes but also increase the incidence and severity of side effects, particularly fluid retention, joint pain, and insulin resistance. The optimal dose balances meaningful physiological effects against acceptable side effect profiles. Current anti-aging research generally favors lower doses (1-2 IU/day) for extended periods rather than higher doses for shorter durations, as this approach appears to provide sustainable benefits with fewer metabolic complications.
Dosing Protocol
HGH dosing for body composition and anti-aging research follows a tiered approach based on the desired outcome. Low-dose anti-aging protocols use 1-2 IU per day (approximately 0.3-0.7 mg/day), which is sufficient to restore IGF-1 levels toward youthful ranges and provide meaningful improvements in skin quality, recovery, sleep depth, and body composition. Moderate body composition doses range from 2-4 IU per day (0.7-1.4 mg/day), producing more pronounced fat loss and lean mass gains. The 36IU vial provides 9-36 days of supply depending on the selected dose level.
Administration is via subcutaneous injection, typically at bedtime to mimic the natural pulsatile GH release pattern that peaks during deep sleep. Begin at the lowest dose and titrate based on IGF-1 blood levels and clinical response. Some protocols employ a 5-days-on, 2-days-off schedule to reduce concerns about insulin resistance with continuous daily dosing. Others use split dosing (half the daily dose in the morning, half before bed) to better approximate natural GH pulsatility.
Starting low and titrating gradually is essential — beginning at 1 IU daily for the first 2-4 weeks allows assessment of individual tolerance before increasing. Monitor IGF-1 levels via blood testing to ensure they remain within the physiological range (typically 200-350 ng/mL for anti-aging applications). Injection sites include the abdomen, thigh, and upper arm, with systematic rotation. For research purposes only — all dosing should be supervised by qualified endocrinologists or anti-aging medicine specialists.
Side Effects & Safety
HGH side effects are well-characterized from extensive clinical use. Common effects (occurring in 1-10% of users) include joint pain (arthralgia), fluid retention and peripheral edema (swelling in hands and feet), carpal tunnel syndrome (numbness and tingling in the hands), headaches, and muscle pain (myalgia). These effects are generally dose-dependent and often resolve with dose reduction.
Metabolic side effects are the most significant concern with HGH therapy. The compound can cause insulin resistance and impaired glucose tolerance, increase fasting blood glucose levels, and potentially increase diabetes risk with prolonged supraphysiological dosing. This is why lower, physiological replacement doses are generally preferred over high-dose protocols. Regular glucose monitoring and HbA1c testing are recommended during any HGH research protocol.
Rare but serious potential complications include acromegaly-like features with chronic excessive dosing (enlarged jaw, hands, feet), hypothyroidism (monitor thyroid function), intracranial hypertension, and theoretical cancer risk due to elevated IGF-1 promoting cellular proliferation. Some research suggests increased risk of cancer, particularly prostate cancer, with chronically elevated IGF-1 levels. Absolute contraindications include active malignancy of any type, active diabetic retinopathy, acute critical illness, and known hypersensitivity. Natural GH production may be suppressed during exogenous administration. This product is for research purposes only.
Storage & Reconstitution
Store the lyophilized HGH 36IU vial at 2-8°C (36-46°F). For extended pre-use storage, the sealed vial can be kept at -20°C. HGH is a relatively large protein (191 amino acids) and is more sensitive to mishandling than smaller peptides. Protect from light, moisture, and mechanical agitation. Keep upright in original packaging until ready for reconstitution.
Reconstitute with bacteriostatic water only. Clean both vial stoppers with alcohol swabs. Using a 21-25 gauge needle, draw the appropriate volume of BAC water. For the 36IU vial, adding 1mL BAC water creates 36IU/mL (each 2IU dose = approximately 0.056mL or ~5.6 units on a U-100 syringe). Adding 3.6mL creates 10IU/mL (each 2IU dose = 0.2mL or 20 units). The latter concentration is more practical for accurate daily dosing. Inject BAC water slowly along the glass wall. Do not shake — HGH is particularly susceptible to denaturation from mechanical stress. Swirl gently until dissolved.
After reconstitution, store at 2-8°C and use within 28 days. Never freeze reconstituted HGH — ice crystal formation irreversibly destroys the large protein structure. In the UAE, where summer temperatures exceed 45°C, cold chain management is critical for HGH. The large molecular size makes it more susceptible to thermal denaturation than smaller peptides. Never leave reconstituted vials outside refrigeration. Use insulated transport containers with cold packs. Verify shipment temperature integrity upon delivery — consider requesting cold-chain shipping with temperature indicators during summer months.
Frequently Asked Questions
What is HGH and how does it work?
HGH (Somatropin) is a recombinant 191-amino acid hormone identical to natural human growth hormone. It promotes fat loss (especially visceral fat), increases lean body mass, improves bone density, enhances tissue repair, and improves skin quality. It works both directly on tissues and indirectly through stimulating IGF-1 production in the liver.
What is the recommended dosing for body composition?
Anti-aging protocols typically use 1-2 IU daily; body composition protocols use 2-4 IU daily. Start at 1 IU and titrate upward based on IGF-1 blood levels and tolerance. Administer subcutaneously at bedtime. Some protocols use a 5-on/2-off schedule to manage insulin sensitivity. The 36IU vial provides 9-36 days of supply depending on dose.
What are the side effects of HGH?
Common side effects include joint pain, fluid retention (swollen hands/feet), carpal tunnel syndrome, headaches, and muscle pain. Metabolic effects include insulin resistance and elevated blood glucose. These are dose-dependent — lower doses produce fewer side effects. Rare complications include acromegaly features with chronic overdosing and theoretical cancer risk from elevated IGF-1.
How does HGH differ from peptide secretagogues like Tesamorelin?
HGH directly replaces growth hormone at constant levels, bypassing the pituitary. Secretagogues like Tesamorelin stimulate endogenous GH release, maintaining natural pulsatile patterns with self-limiting negative feedback. HGH is more potent and predictable but has more side effects and suppresses natural production. Secretagogues are generally better tolerated and more affordable.
How should HGH be stored?
Store lyophilized vials at 2-8°C (or -20°C long-term). After reconstitution, refrigerate and use within 28 days. Never freeze reconstituted HGH. The large protein structure makes it more heat-sensitive than smaller peptides — strict cold chain management is essential in the UAE climate.
Disclaimer: This product is sold for laboratory research purposes only. Not for human consumption. All information provided is for educational purposes and does not constitute medical advice. Consult a qualified healthcare provider before starting any peptide protocol.
